1. TL1A/DR3 Axis, A Key Target of TNF-a, Augments the Epithelial–Mesenchymal Transformation of Epithelial Cells in OVA-Induced Asthma
   Dong Zhang et al, 2022, Frontiers in Immunology CrossRef
2. Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy
   Sebastian Bittner et al, 2022, Proceedings of the National Academy of Sciences CrossRef
3. The landscape of new therapeutic opportunities for IBD
   Andrés Hurtado-Lorenzo et al, 2024, Emerging Therapeutic Targets and Drug Delivery Approaches in IBD CrossRef
4. Markers and makers of NKT17 cells
   Nurcin Liman et al, 2023, Experimental & Molecular Medicine CrossRef
5. Antibodies Targeting the Tumor Necrosis Factor-Like Ligand 1A in Inflammatory Bowel Disease: A New Kid on the (Biologics) Block?
   Daniel Schweckendiek et al, 2024, Digestion CrossRef
6. Update on transfusion-related acute lung injury: an overview of its pathogenesis and management
   Yunhong Yu et al, 2023, Frontiers in Immunology CrossRef
7. Anti-TL1A monoclonal antibody modulates the dysregulation of Th1/Th17 cells and attenuates granuloma formation in sarcoidosis by inhibiting the PI3K/AKT signaling pathway
   Chengxing Ma et al, 2024, International Immunopharmacology CrossRef
8. Role of TL1A in Inflammatory Autoimmune Diseases: A Comprehensive Review
   Wang-Dong Xu et al, 2022, Frontiers in Immunology CrossRef